Entries by aaron

CDSCO Panel Approves New Indications for Novo Nordisk’s Semaglutide, Mandates PMS Study

New Delhi: Recommending to conduct post marketing surveillance (PMS) study in India, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted approval to the drug major Novo Nordisk India for the additional indication of the drug Semaglutide Injection 0.25 mg, 0.5 mg, and 1 mg. The additional indications […]

ESIC Medical College Hospital Chennai unveils Rs 4.03 crore Cath Lab facility

Chennai: ESIC Medical College and Hospital, KK Nagar, Chennai, marked a significant milestone in its journey towards enhanced healthcare delivery with the inauguration of the Cath Lab services.  This facility is set to significantly improve cardiac diagnostic and interventional services for ESI beneficiaries in the region. The inauguration ceremony was presided over by Shri Ashok […]

Intas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic Dermatitis

New Delhi: Intas Pharma has received approval from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) for the results of its Post-Marketing Surveillance (PMS) study on Tofacitinib 2% w/w ointment in adult patients with mild to moderate atopic dermatitis, including those experiencing flare-ups. The update was discussed during the SEC’s […]

CM Siddaramaiah pays surprise visit to Victoria Hospital, calls for expansion

Bengaluru: Karnataka Chief Minister Siddaramaiah pays a surprise visit to the government-run Victoria Hospital on Wednesday. He stressed the urgent need to expand the capacity of the hospital, amid the growing number of patients arriving from across the country. He paid a surprise visit to the hospital along with Medical Education Minister Sharan Prakash Patil […]

Walking Faster and Farther Reduces CV Risk among People with High Blood Pressure: Study

Analysis of over 36,000 people with high blood pressure has shown that taking more steps, even below the recommended daily target of 10,000 steps, and walking faster, is associated with a significant reduction in the risk of major problems of the heart and blood vessels. The study, published in the European Journal of Preventive Cardiology, […]

CGM Metrics Strongly Predict 5-Year Mortality Risk in Diabetes, Study Shows

USA: A new long-term analysis published in Diabetes Care has highlighted the potential of continuous glucose monitoring (CGM) metrics to predict the risk of death among individuals with type 1 or type 2 diabetes. The study, led by Tomoki Okuno from the Department of Biostatistics at the University of California, Los Angeles, in collaboration with […]

SGLT2 Inhibitors Fail to Impact MI Severity or Outcomes in T2DM Patients: Study

Germany: A retrospective cohort study has found that prior use of SGLT2 inhibitors in type 2 diabetes mellitus (T2DM) patients did not reduce myocardial infarction (MI) size or decrease adverse events during hospitalization for MI treated with percutaneous coronary intervention (PCI). The study, published in BMC Cardiovascular Disorders by Istvan Bojti and colleagues from the […]

DMARD Use and Rheumatoid Arthritis Raise Mortality in Bronchiectasis Patients: Study Shows

South Korea: A large-scale study from South Korea has found that individuals living with both bronchiectasis and rheumatoid arthritis face more than double the risk of death compared to those with bronchiectasis alone. The research, published in Therapeutic Advances in Respiratory Disease, also indicates that RA seropositivity and the use of disease-modifying anti-rheumatic drugs may […]

Low vitamin B12 levels associated with primary monosymptomatic nocturnal enuresis: Study

A new study published in the Journal of Pediatric Urology found that children who have low or borderline vitamin B12 levels are more prone to experience primary monosymptomatic nocturnal enuresis (PMNE). Urinary control systems may be impacted by micronutrient deficits, especially those involving vitamin B12. The most prevalent voiding issue in the pediatric population is […]

Pain Meets Peace: Study Evaluates Dexmedetomidine in Chronic Pain with Anxiety and Depression

Chronic pain frequently coexists with anxiety and depression, complicating treatment outcomes and exacerbating patients’ suffering. Dexmedetomidine (DEX), a selective α2-adrenoreceptor agonist used primarily in perioperative settings, has shown promise in alleviating these co-occurring symptoms due to its analgesic and anxiolytic properties. However, its application in chronic pain patients who also suffer from anxiety and depression […]